Singapore-headquartered Doctor Anywhere (DA) raised US$65.7 million in Series C funding, bringing total investment to more than US$104 million.
Led by Asia Partners, this round of funding includes investors such as Novo Holdings, Philips and OSK-SBI Venture Partners.
Since its launch in 2017, the digital health platform has grown exponentially to serve more than 1.5 million users across Southeast Asia. COVID-19 has served as a catalyst to fast-track the adoption of telehealth services over the past 18 months.
DA has built a strong ecosystem of payers, providers, and patients across its core markets. It has nearly 2,800 doctors and medical professionals in its regional network in the region, and works closely with major hospitals and healthcare institutions.
“We will utilise this funding to further enhance our digital capabilities, and scale up on our ability to deliver quality healthcare seamlessly to our users in Southeast Asia,” said Lim Wai Mun, Founder and CEO of DA.
DA is available in Singapore, Malaysia, Thailand, Vietnam, and the Philippines with regional tech hubs in Bangalore, India, and Ho Chi Minh City, Vietnam.